ZimVie (NASDAQ:ZIMV – Get Rating) will be releasing its earnings data after the market closes on Thursday, May 5th. Persons that wish to listen to the company’s earnings conference call can do so using this link. ZimVie stock opened at $22.95 on Thursday. The company has a quick ratio of 1.57, a current ratio of […]
ZimVie (NASDAQ:ZIMV – Get Rating) and BIOLASE (NASDAQ:BIOL – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, analyst recommendations, institutional ownership, risk and valuation. Earnings & Valuation This table compares ZimVie and BIOLASE’s gross revenue, […]
ZimVie (NASDAQ:ZIMV – Get Rating) and Item 9 Labs (OTC:INLB – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, earnings, valuation, profitability, analyst recommendations and dividends. Analyst Ratings This is a summary of recent ratings […]
ZimVie (NASDAQ:ZIMV – Get Rating) and Sartorius Aktiengesellschaft (OTCMKTS:SARTF – Get Rating) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, dividends, profitability, risk and institutional ownership. Profitability This table compares ZimVie and Sartorius Aktiengesellschaft’s net margins, return […]
ZimVie (NASDAQ:ZIMV – Get Rating) issued an update on its FY 2022 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $2.100-$2.300 for the period, compared to the Thomson Reuters consensus estimate of $2.150. The company issued revenue guidance of $1 billion-$1 billion, compared to the consensus revenue estimate of […]